Home > Healthcare > Pharmaceuticals > Vaccines > Combination Vaccines Market

Combination Vaccines Market Share

Report ID: GMI6086
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Combination Vaccines Market Share

Major players operating in the combination vaccines business landscape are

Sanofi Pasteur
GlaxoSmithKline (GSK)
Merck & Co., Inc.
Panacea Biotec
Sinovac Biotech
Serum Institute of India

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition. Also, kindly note that the company profile section include both companies that have commercial drug available in market as well as those that are into clinical phase development.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of combination vaccines was worth USD 4.6 billion in 2022 and is projected to register 10.9% CAGR from 2023 to 2032 attributed to the increasing emphasis on preventive healthcare globally along with the rising focus on vaccination as a crucial preventive measure.

Combination vaccines industry size from the conjugate technology segment is estimated to cross USD 5.1 billion by 2032 owing to the massive R&D investments by pharmaceutical companies and government organizations.

North America held 40.8% of the global industry share in 2022 and is anticipated to exhibit robust growth till 2032 driven by the presence of favorable regulatory environment and the high prevalence of infectious diseases across the region.

Leading combination vaccines companies are Sanofi Pasteur, GlaxoSmithKline (GSK), Merck & Co., Inc., Panacea Biotec, Sinovac Biotech, and Serum Institute of India, among others.